Dose-dependent expression of neuronal injury markers during experimental osteoarthritis induced by monoiodoacetate in the rat

Molecular Pain

Volumn 8, Issue , 2012, Pages

  Ferreira Gomes, Joana ^a   Adães, Sara ^a   Sousa, Raquel M ^a   Mendonça, Marcelo ^a   Castro Lopes, José M ^a  

^a University of Porto   (Portugal)

Author keywords

ATF 3; GAP 43; Mono iodoacetate; Neuronal injury; NPY; Osteoarthritis; Pain

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; IODOACETIC ACID; NEUROMODULIN; NEUROPEPTIDE Y;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; MALE; NERVE INJURY; NOCICEPTION; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL GANGLION; UPREGULATION;

ACTIVATING TRANSCRIPTION FACTOR 3; ANIMALS; BEHAVIOR, ANIMAL; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; GANGLIA, SPINAL; GAP-43 PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; IODOACETIC ACID; KNEE JOINT; LUMBAR VERTEBRAE; MALE; NEURONS; NEUROPEPTIDE Y; OSTEOARTHRITIS, KNEE; RATS; RATS, WISTAR;

EID: 84863500917     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-8-50     Document Type: Article

References (55)

1. Hart FD. Pain in osteoarthrosis. Practitioner 1974, 212:244-250.
2. Just S, Pawlak M, Heppelmann B. Responses of fine primary afferent nerve fibres innervating the rat knee joint to defined torque. J Neurosci Methods 2000, 103:157-162. 10.1016/S0165-0270(00)00310-1, 11084208.
3. Schaible HG, Schmidt RF. Responses of fine medial articular nerve afferents to passive movements of knee joints. J Neurophysiol 1983, 49:1118-1126.
4. Guzman RE, Evans MG, Bove S, Morenko B, Kilgore K. Mono-iodoacetate-induced histologic changes in subchondral bone and articular cartilage of rat femorotibial joints: an animal model of osteoarthritis. Toxicol Pathol 2003, 31:619-624.
5. Kalbhen DA. Chemical model of osteoarthritis - a pharmacological evaluation. J Rheumatol 1987, 14:130-131.
6. Ivanavicius SP, Ball AD, Heapy CG, Westwood FR, Murray F, Read SJ. Structural pathology in a rodent model of osteoarthritis is associated with neuropathic pain: increased expression of ATF-3 and pharmacological characterization. Pain 2007, 128:272-282. 10.1016/j.pain.2006.12.022, 17276007.
7. Ferreira-Gomes J, Adaes S, Sarkander J, Castro-Lopes JM. Phenotypic alterations of neurons that innervate osteoarthritic joints in rats. Arthritis Rheum 2010, 62:3677-3685. 10.1002/art.27713, 20722015.
8. Hanz S, Fainzilber M. Retrograde signaling in injured nerve-the axon reaction revisited. J Neurochem 2006, 99:13-19. 10.1111/j.1471-4159.2006.04089.x, 16899067.
9. McIlwain DL, Hoke VB. Magnitude, laterality, and uniformity of swelling in axotomized spinal motoneurons: lack of evidence for influence by the distal stump. Exp Neurol 1999, 157:161-168. 10.1006/exnr.1999.7051, 10222119.
10. Michael GJ, Averill S, Shortland PJ, Yan Q, Priestley JV. Axotomy results in major changes in BDNF expression by dorsal root ganglion cells: BDNF expression in large trkB and trkC cells, in pericellular baskets, and in projections to deep dorsal horn and dorsal column nuclei. Eur J Neurosci 1999, 11:3539-3551. 10.1046/j.1460-9568.1999.00767.x, 10564362.
11. Zhou XF, Chie ET, Deng YS, Zhong JH, Xue Q, Rush RA, Xian CJ. Injured primary sensory neurons switch phenotype for brain-derived neurotrophic factor in the rat. Neuroscience 1999, 92:841-853. 10.1016/S0306-4522(99)00027-5, 10426526.
12. Bráz JM, Basbaum AI. Differential ATF3 expression in dorsal root ganglion neurons reveals the profile of primary afferents engaged by diverse noxious chemical stimuli. Pain 2010, 150:290-301. 10.1016/j.pain.2010.05.005, 2922479, 20605331.
13. Tsujino H, Kondo E, Fukuoka T, Dai Y, Tokunaga A, Miki K, Yonenobu K, Ochi T, Noguchi K. Activating transcription factor 3 (ATF3) induction by axotomy in sensory and motoneurons: a novel marker of nerve injury. Mol Cell Neurosci 2000, 15:170-182. 10.1006/mcne.1999.0814, 10673325.
14. Gibson SJ, Polak JM, Allen JM, Adrian TE, Kelly JS, Bloom SR. The distribution and origin of a novel brain peptide, neuropeptide Y, in the spinal cord of several mammals. J Comp Neurol 1984, 227:78-91. 10.1002/cne.902270109, 6432858.
15. Hokfeldt T, Brumovsky P, Shi T, Pedrazzini T, Villar M. NPY and pain as seen from the histochemical side. Peptides 2007, 28:365-372. 10.1016/j.peptides.2006.07.024, 17234301.
16. Brumovsky P, Shi TS, Landry M, Villar MJ, Hökfelt T. Neuropeptide tyrosine and pain. Trends Pharmacol Sci 2007, 28:93-102. 10.1016/j.tips.2006.12.003, 17222466.
17. Wakisaka S, Kajander KC, Bennett GJ. Increased neuropeptide Y (NPY)-like immunoreactivity in rat sensory neurons following peripheral axotomy. Neurosci Lett 1991, 124:200-203. 10.1016/0304-3940(91)90093-9, 1712437.
18. Chong MS, Fitzgerald M, Winter J, Hu-Tsai M, Emson PC, Wiese U, Wool CJ. GAP-43 mRNA in rat spinal cord and dorsal root ganglia neurons: development changes and re-expression following peripheral nerve injury. Eur J Neurosci 1992, 4:883-895. 10.1111/j.1460-9568.1992.tb00115.x, 12106424.
19. Sommervaille T, Reynolds ML, Woolf CJ. Time-dependent differences in the increase in GAP-43 expression in dorsal root ganglion cells after peripheral axotomy. Neuroscience 1991, 45:213-220. 10.1016/0306-4522(91)90117-7, 1836547.
20. Woolf CJ, Reynolds ML, Molander C, ÓBrien C, Lindsay RM, Benowitz LI. The growth-associated protein GAP-43 appears in dorsal root ganglion cells and in the dorsal horn of the rat spinal cord following peripheral nerve injury. Neuroscience 1990, 34:465-478. 10.1016/0306-4522(90)90155-W, 2139720.
21. Schuelert N, McDougall JJ. Grading of monosodium iodoacetate-induced osteoarthritis revelas a concentration-dependent sensitization of nociceptors in the knee joint of the rat. Neurosc Lett 2009, 465:184-188.
22. Bove SE, Calcaterra SL, Brooker RM, Huber CM, Guzman RE, Juneau PL, Schrier DJ, Kilgore KS. Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthritis Cartilage 2003, 11:821-830. 10.1016/S1063-4584(03)00163-8, 14609535.
23. Combe R, Bramwell S, Fielf MJ. The monosodium iodoacetate model of osteoarthritis: A model of chronic nociceptive pain in rats?. Neurosci Lett 2004, 370:236-240. 10.1016/j.neulet.2004.08.023, 15488329.
24. Fernihough J, Gentry C, Malcangio M, Fox A, Rediske J, Pellas T, Kidd B, Bevan S, Winter J. Pain related behavior in two models of osteoarthritis in the rat knee. Pain 2004, 112:83-93. 10.1016/j.pain.2004.08.004, 15494188.
25. Guingamp C, Gegout-Pottie P, Philippe L, Terlain B, Netter P, Gillet P. Mono-iodoacetate-induced experimental osteoarthritis: a dose-response study of loss of mobility, morphology, and biochemistry. Arthritis Rheum 1997, 40:1670-1679. 10.1002/art.1780400917, 9324022.
26. Pomonis JD, Boulet JM, Gottshall SL, Phillips S, Sellers R, Bunton T, Walker K. Development and pharmacological characterization of a rat model of osteoarthritis pain. Pain 2005, 114:339-346. 10.1016/j.pain.2004.11.008, 15777859.
27. Kobayashi K, Imaizumi R, Sumichika H, Tanaka H, Goda M, Fukunari A, Komatsu H. Sodium iodoacetate-induced experimental osteoarthritis and associated pain model in rats. J Vet Med Sci 2003, 65:1195-1199. 10.1292/jvms.65.1195, 14665748.
28. Orita S, Ishikawa T, Miyagi M, Ochiai N, Inoue G, Eguchi Y, Kamoda H, Arai G, Toyone T, Aoki Y, Kubo T, Takahashi K, Ohtori S. Pain-related sensory innervation in monoiodoacetate-induced osteoarthritis in rat knees that gradually develops neuronalinjury in addition to inflammatory pain. BMC Musculoskelet Disord 2011, 12:134. 10.1186/1471-2474-12-134, 3142251, 21679434.
29. Hill CE, Harrison BJ, Rau KK, Hougland MT, Bunge MB, Mendell LM, Petruska JC. Skin incision induces expression of axonal regeneration-related genes in adult rat spinal sensory neurons. J Pain 2010, 11:1066-1073. 10.1016/j.jpain.2010.02.001, 2955994, 20627820.
30. Inglis JJ, Notley CA, Essex D, Wilson AW, Feldman M, Anand P, Williams R. Collagen-induced arthritis as a model of hyperalgesia: functional and cellular analysis of the analgesic actions of tumor necrosis factor blockade. Arthritis Rheum 2007, 56:4015-4023. 10.1002/art.23063, 18050216.
31. Nascimento D, Pozza DH, Castro-Lopes JM, Neto FL. Neuronal Injury Marker ATF-3 Is Induced in Primary Afferent Neurons of Monoarthritic Rats. Neurosignals 2011, 19:210-221. [Epub ahead of print], 10.1159/000330195, 21912089.
32. Shortland PJ, Baytug B, Krzyzanowska A, McMahon SB, Priestley JV, Averill S. ATF3 expression in L4 dorsal root ganglion neurons after L5 spinal nerve transection. Eur J Neurosci 2006, 23:365-373. 10.1111/j.1460-9568.2005.04568.x, 16420444.
33. Gravallese EM. Bone destruction in arthritis. Ann Rheum Dis 2002, 61(Suppl 2):ii84-ii86. 1766721, 12379632.
34. Vermeirsch H, Biermans R, Salmon PL, Meert TF. Evaluation of pain behavior and bone destruction in two arthritic models in guinea pig and rat. Pharmacol Biochem Behav 2007, 87:349-359. 10.1016/j.pbb.2007.05.010, 17583780.
35. Abdulla FA, Smith PA. Nerve injury increases an excitatory action of neuropeptide Y and Y2-agonists on dorsal root ganglion neurons. Neuroscience 1999, 89:43-60. 10.1016/S0306-4522(98)00443-6, 10051216.
36. Devor M, Janig W, Michaelis M. Modulation of activity in dorsal root ganglion neurons by sympathetic activation in nerve-injured rats. J Neurophysiol 1994, 71:38-47.
37. Ji RR, Zhang X, Wiesenfeld-Hallin Z, Hökfelt T. Expression of neuropeptide Y and neuropeptide Y (Y1) receptor mRNA in rat spinal cord and dorsal root ganglia following peripheral tissue inflammation. J Neurosci 1994, 14:6423-6434.
38. Wakisaka S, Kajander KC, Bennett GJ. Effects of peripheral nerve injuries and tissue inflammation on the levels of neuropeptide Y-like immunoreactivity in rat primary afferent neurons. Brain Res 1992, 598:349-352. 10.1016/0006-8993(92)90206-O, 1486499.
39. Michaelis M, Devor M, Jänig W. Sympathetic modulation of activity in rat dorsal root ganglion neurons changes over time following peripheral nerve injury. J Neurophysiol 1996, 76:753-763.
40. Creamer P. Osteoarthritis pain and its treatment. Curr Opin Rheumatol 2000, 12:450-455. 10.1097/00002281-200009000-00019, 10990186.
41. Dieppe P. Subchondral bone should be the main target for the treatment of pain and disesase progression in osteoarthritis. Osteoarthritis Cartilage 1999, 7:325-326. 10.1053/joca.1998.0182, 10329316.
42. Niv D, Gofeld M, Devor M. Causes of pain in degenerative bone and joint disease: a lesson from vertebroplasty. Pain 2003, 105:387-392. 10.1016/S0304-3959(03)00277-X, 14527699.
43. Lieberman AR. The axon reaction: a review of the principal features of perikaryal responses to axon injury. Int Rev Neurobiol 1971, 14:49-124.
44. Fawcett JW, Geller HM. Regeneration in the CNS: optimism mounts. Trends Neurosci 1998, 21:179-180. 10.1016/S0166-2236(98)01241-7, 9610878.
45. Nakagomi S, Suzuki Y, Namikawa K, Kiryu-Seo S, Kiyama H. Expression of the activating transcription factor 3 prevents c-Jun N-terminal kinase-induced neuronal death by promoting heat shock protein 27 expression and Akt activation. J Neurosci 2003, 23:5187-5196.
46. Thompson MR, Xu D, Williams BRG. ATF3 transcription factor and its emerging roles in immunity and cancer. J Mol Med 2009, 87:1053-1060. 10.1007/s00109-009-0520-x, 2783469, 19705082.
47. Bisby MA. Dependence of GAP43 (B50, F1) transport on axonal regeneration in rat dorsal root ganglion neurons. Brain Res 1988, 458:157-161. 10.1016/0006-8993(88)90509-4, 2463041.
48. Doster SK, Lozano AM, Aguayo AJ, Willard MB. Expression of the growth-associated protein GAP-43 in adult rat retinal ganglion cells following axon injury. Neuron 1991, 6:635-647. 10.1016/0896-6273(91)90066-9, 1826603.
49. Tetzlaff W, Alexander SW, Miller FD, Bisby MA. Response of facial and rubrospinal neurons to axotomy: changes in mRNA expression for cytoskeletal proteins and GAP-43. J Neurosci 1991, 11:2528-2544.
50. Courtney CA, Kavchak AE, Lowry CD, O'Hearn MA. Interpreting joint pain: quantitative sensory testing in musculoskeletal management. J Orthop Sports Phys Ther 2010, 40:818-825.
51. Hochman JR, French MR, Bermingham SL, Hawker GA. The nerve of osteoarthritis pain. Arthritis Care Res (Hoboken) 2010, 62:1019-1023.
52. Wylde V, Hewlett S, Learmonth ID, Dieppe P. Persistent pain after joint replacement: Prevalence, sensory qualities, and postoperative determinants. Pain 2011, 152:566-572. 10.1016/j.pain.2010.11.023, 21239114.
53. Barve RA, Minnerly JC, Weiss DJ, Meyer DM, Aguiar DJ, Sullivan PM, Weinrich SL, Head RD. Transcriptional profiling and pathway analysis of monosodium iodoacetate-induced experimental osteoarthritis in rats: relevance to human disease. Osteoarthritis Cartilage 2007, 15:1190-1198. 10.1016/j.joca.2007.03.014, 17500014.
54. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110. 10.1016/0304-3959(83)90201-4, 6877845.
55. Ferreira-Gomes J, Adães S, Castro-Lopes JM. Assessment of movement-evoked pain in osteoarthritis by the Knee-Bend and CatWalk tests: a clinically relevant study. J Pain 2008, 9:945-954. 10.1016/j.jpain.2008.05.012, 18650131.